Test Price
850 AED✅ Home Collection Available
Ganglioside Antibody Profile IgM Test in UAE | 850 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189:2012 Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
This profile detects pathogenic IgM autoantibodies targeting GM1, GD1a, GD1b, GQ1b, and related gangliosides, providing essential serological evidence for diagnosing immune-mediated peripheral neuropathies including acute motor axonal neuropathy and Miller Fisher syndrome.
Test Overview & Methodology
The Ganglioside Antibody Profile IgM employs advanced immunoblot technology to simultaneously screen for multiple anti-ganglioside IgM antibodies in human serum. This multiplexed approach surpasses conventional ELISA by enabling simultaneous detection of GM1, GD1a, GD1b, and GQ1b reactivities from a single specimen, reducing turnaround time and improving diagnostic specificity for autoimmune neuropathies.
| Feature | DNA Labs UAE – Premium Service | Standard Lab Alternative |
|---|---|---|
| Precision | Immunoblot with multispecific antigen profiling | ELISA limited to single ganglioside |
| Methodology | Advanced Immunoblot (DHA-validated, CE-IVD) | Conventional ELISA |
| Turnaround Time | Same day if sample received by 9 AM | 3–5 working days |
| Logistics | Cold-chain home collection 8 AM–11 PM | Patient travel required |
Physician Insight & Safety Protocols
Dr. Ajay Singh (DHA Registration ID: 36234132), General Practitioner, advises: "The Ganglioside IgM profile is a valuable serological adjunct in the workup of suspected immune-mediated neuropathy. A reactive result must be correlated with nerve conduction studies and clinical phenotype. Positive serology alone does not confirm diagnosis—urgent neurological evaluation is warranted when patients present with new or progressive weakness, especially following an infectious illness."
Medication Advisory
Do not discontinue prescribed immunosuppressants, corticosteroids, or anticoagulants without direct consultation with your treating physician. Abrupt changes can precipitate serious disease flares or thrombotic events.
Safety Exclusion Criteria & Emergency Red Flags
- Active unexplained fever within 48 hours (may confound immune results)
- Coagulopathy or severe thrombocytopenia (platelets < 50,000/µL) – risk of hematoma
- Emergency signs: Sudden respiratory distress, bulbar palsy, or rapidly ascending paralysis – Call 998 immediately
Patient FAQ & Clinical Guidance
1. What is the Ganglioside Antibody Profile IgM test and why is it important?
This blood test detects pathogenic IgM autoantibodies that attack peripheral nerve gangliosides, enabling early diagnosis of acute motor axonal neuropathy, Miller Fisher syndrome, and multifocal motor neuropathy. Early detection allows timely intervention with plasmapheresis or intravenous immunoglobulin, potentially reducing long-term nerve damage.
2. How should I prepare for the blood sample collection?
No fasting is required; simply maintain hydration. Our trained phlebotomist will collect 2 mL of serum in an SST tube using standard venipuncture. The sample is immediately placed in temperature-controlled cold-chain transport to preserve antibody integrity.
3. What steps should I take if the result is positive?
A positive result warrants prompt neurological consultation. Your report includes a direct hotline to schedule an appointment with our neurology network. Do not delay—early treatment correlates with improved functional outcomes in immune-mediated neuropathies.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
All clinical data processing and laboratory testing at DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring patient information is collected, stored, and transmitted under lawful data governance standards.
Health information security protocols comply with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, mandating encrypted data transfer, access control logging, and breach notification procedures.
Clinical testing safety, patient consent, and medical liability are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring all diagnostic procedures meet statutory standards for patient safety and informed consent.
The laboratory operates under DHA Facility License Number 1143 and maintains ISO 15189:2012 accreditation for medical laboratory quality and competence.
Clinical & Logistical Metadata
| Test Name | Ganglioside Antibody Profile IgM (Immunoblot) |
| Price (AED) | 850 |
| Turnaround Time | Same day (sample received by 9 AM); standard 24–48 hours |
| Sample Type / Matrix | Serum (2 mL in SST tube) |
| Methodology Used | Immunoblot (CE-IVD, DHA-validated) |
| ICD-10-CM Code | G61.0 (Guillain-Barré syndrome) |
| LOINC Code | 102715-4 (Ganglioside antibodies panel [Interpretation] in Serum) |
| DHA Facility License & Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians